M. Rahbar, Z. S. Naraghi, M. Mardanpour, and N. Mardanpour, Tumor-Infiltrating CD8+ Lymphocytes Effect on Clinical Outcome of Muco-Cutaneous Melanoma, Indian J. Dermatol, vol.60, p.212, 2015.

E. Sato, S. Olson, J. Ahn, B. Bundy, H. Nishikawa et al., Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer, Proc. Natl. Acad. Sci, vol.102, pp.18538-18543, 2005.

J. Galon, A. Coleno-costes, A. Kirilovsky, B. Mlecnik, C. Lagorce-pagès et al., Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, Science, vol.313, 1960.

P. Sharma, Y. Shen, S. Wen, S. Yamada, A. A. Jungbluth et al., CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma, Proc. Natl. Acad. Sci, vol.104, pp.3967-3972, 2007.

S. M. Mahmoud, E. C. Paish, D. G. Powe, R. D. Macmillan, M. Grainge et al., Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer, J. Clin. Oncol, vol.29, 1949.

J. Carstens, P. C. De-sampaio, D. Yang, S. Barua, H. Wang et al., Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer, Nat. Commun, vol.8, 2017.

D. Kabelitz, L. Marischen, H. Oberg, W. Holtmeier, and D. Wesch, Epithelial Defence by ?? T Cells. Int. Arch. Allergy Immunol, vol.137, pp.73-81, 2005.

C. R. Willcox, V. Pitard, S. Netzer, L. Couzi, M. Salim et al., Cytomegalovirus and tumor stress surveillance by binding of a human ?? T cell antigen receptor to endothelial protein C receptor, Nat. Immunol, vol.13, pp.872-879, 2012.

F. Bouet-toussaint, F. Cabillic, O. Toutirais, M. Le-gallo, C. T. De-la-pintière et al., V?9V?2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas, Cancer Immunol. Immunother, vol.57, pp.531-539, 2007.

A. Cordova, F. Toia, C. La-mendola, V. Orlando, S. Meraviglia et al., Characterization of Human ?? T Lymphocytes Infiltrating Primary Malignant Melanomas, PLoS ONE, vol.7, 2012.

M. Corvaisier, A. Moreau-aubry, E. Diez, J. Bennouna, J. Mosnier et al., V?9V?2 T Cell Response to Colon Carcinoma Cells, J. Immunol, vol.175, pp.5481-5488, 2005.

S. Meraviglia, M. Eberl, D. Vermijlen, M. Todaro, S. Buccheri et al., In vivo manipulation of V?9V?2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients, Clin. Exp. Immunol, vol.161, pp.290-297, 2010.

M. R. Raspollini, F. Castiglione, D. R. Degl'innocenti, G. Amunni, A. Villanucci et al., Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma, Ann. Oncol, vol.16, pp.590-596, 2005.

E. L. Presti, G. Pizzolato, E. Gulotta, G. Cocorullo, F. Dieli et al., Current Advances in ?? T Cell-Based Tumor Immunotherapy, Front. Immunol, vol.8, issue.8, 2017.

D. Marquez-medina, J. Salla-fortuny, and A. Salud, Role of gamma-delta T-cells in cancer, Clin. Transl. Oncol, vol.14, pp.891-895, 2012.

C. D. Pauza, M. Liou, T. Lahusen, L. Xiao, R. G. Lapidus et al., Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local, Front. Immunol, vol.9, issue.9, 2018.

J. G. Pressey, J. Adams, L. Harkins, D. R. Kelly, Z. You et al., In vivo expansion and activation of ?? T cells as immunotherapy for refractory neuroblastoma, Medicine, vol.95, 2016.

E. J. Adams, S. Gu, and A. M. Luoma, Human gamma delta T cells: Evolution and ligand recognition, Cell. Immunol, vol.296, pp.31-40, 2015.

M. Bonneville, R. L. O'brien, and W. K. Born, ?? T cell effector functions: A blend of innate programming and acquired plasticity, Nat. Rev. Immunol, vol.10, pp.467-478, 2010.

E. L. Presti, F. Dieli, and S. Meraviglia, Tumor-Infiltrating Π3 δT Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment, Front. Immunol, vol.5, p.607, 2014.

R. Salgado, C. Denkert, S. Demaria, N. Sirtaine, F. Klauschen et al., The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: Recommendations by an International TILs Working Group, Ann. Oncol, vol.26, pp.259-271, 2014.

G. Chabab, C. Barjon, N. Abdellaoui, L. Salvador-prince, C. Dejou et al., Identification of a regulatory Vdelta1 gamma delta T cell subpopulation expressing CD73 in human breast cancer, J. Leukoc. Biol, vol.107, pp.1057-1067, 2020.

J. Brierley, M. Gospodarowicz, and B. O'sullivan, The principles of cancer staging, vol.10, p.61, 2016.

T. Donnem, T. K. Kilvaer, S. Andersen, E. Richardsen, E. E. Paulsen et al., Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer, Ann. Oncol, vol.27, pp.225-232, 2016.

J. Galon, F. Pagès, F. M. Marincola, H. K. Angell, M. Thurin et al., Cancer classification using the Immunoscore: A worldwide task force, J. Transl. Med, vol.10, p.205, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00780742

A. A. Jungbluth, D. Frosina, M. Fayad, M. P. Pulitzer, A. Dogan et al., Immunohistochemical Detection of ?/? T Lymphocytes in Formalin-fixed Paraffin-embedded Tissues, Appl. Immunohistochem. Mol. Morphol, vol.27, pp.581-583, 2019.

S. Upadhrasta and L. Zheng, Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune "Defects" in the Tumor Microenvironment, J. Clin. Med, 1472.

C. Ma, Q. Zhang, J. Ye, F. Wang, Y. Zhang et al., Tumor-infiltrating ?? T lymphocytes predict clinical outcome in human breast cancer, J. Immunol, vol.189, pp.5029-5036, 2012.

C. Yam, S. A. Mani, and S. L. Moulder, Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field, Oncologist, vol.22, pp.1086-1093, 2017.

J. Ye, C. Ma, E. C. Hsueh, C. Eickhoff, Y. Zhang et al., Tumor-derived ?? regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence, J. Immunol, vol.190, pp.2403-2414, 2013.

J. V. Hidalgo, P. Bronsert, M. Orlowska-volk, L. B. Díaz, E. Stickeler et al., Histological Analysis of ?? T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas, Front. Immunol, vol.5, 2014.

Y. Wu, F. Kyle-cezar, R. T. Woolf, C. Naceur-lombardelli, J. Owen et al., An innate-like V?1+ ?? T cell compartment in the human breast is associated with remission in triple-negative breast cancer, Sci. Transl. Med, vol.11, 2019.

S. Tejpar, S. Stintzing, F. Ciardiello, J. Tabernero, E. Van-cutsem et al., Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer, JAMA Oncol, vol.3, pp.194-201, 2017.

R. Gupta, S. Sinha, and R. N. Paul, The impact of microsatellite stability status in colorectal cancer, Curr. Probl. Cancer, vol.42, pp.548-559, 2018.

T. Yokota, T. Ura, N. Shibata, D. Takahari, K. Shitara et al., BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer, British J. Cancer, vol.104, pp.856-862, 2011.

Z. X. Yuan, X. Y. Wang, Q. Y. Qin, D. F. Chen, Q. H. Zhong et al., The prognostic role of BRAF mutation in metastatic colorectal cancer receiving anti-EGFR monoclonal antibodies: A meta-analysis, PLoS ONE, vol.8, 2013.

A. Rowland, M. M. Dias, M. D. Wiese, G. Kichenadasse, R. A. Mckinnon et al., Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer, British J. Cancer, vol.112, pp.1888-1894, 2015.

H. Kayhanian, E. Goode, F. Sclafani, J. E. Ang, M. Gerlinger et al., Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study, Clin. Colorectal Cancer, vol.17, pp.69-76, 2018.

S. Meraviglia, E. Lo-presti, M. Tosolini, C. La-mendola, V. Orlando et al., Distinctive features of tumor-infiltrating gammadelta T lymphocytes in human colorectal cancer, vol.6, 2017.

F. Pages, J. Galon, M. C. Dieu-nosjean, E. Tartour, C. Sautes-fridman et al., Immune infiltration in human tumors: A prognostic factor that should not be ignored, Oncogene, vol.29, pp.1093-1102, 2010.

M. Tosolini, F. Pont, M. Poupot, F. Vergez, M. Nicolau-travers et al., Assessment of tumor-infiltrating TCRV?9V?2??lymphocyte abundance by deconvolution of human cancers microarrays, vol.6, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02472196

M. Yarchoan, B. A. Johnson, E. R. Lutz, D. A. Laheru, and E. M. Jaffee, Targeting neoantigens to augment antitumour immunity, Nat. Rev. Cancer, vol.17, pp.209-222, 2017.

J. Blando, A. Sharma, M. G. Higa, H. Zhao, L. Vence et al., Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer, Proc. Natl. Acad. Sci, vol.116, pp.1692-1697, 2019.

C. Feig, A. Gopinathan, A. Neesse, D. S. Chan, N. Cook et al., The pancreas cancer microenvironment, Clin. Cancer Res, vol.18, pp.4266-4276, 2012.

S. Lunardi, R. Muschel, and T. B. Brunner, The stromal compartments in pancreatic cancer: Are there any therapeutic targets?, Cancer Lett, vol.343, pp.147-155, 2014.

M. Timmermans, G. Sonke, . Van-de, K. Vijver, M. Van-der-aa et al., No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands, Eur. J. Cancer, vol.88, pp.31-37, 2018.

X. Chen, W. Shang, R. Xu, M. Wu, X. Zhang et al., Distribution and functions of ?? T cells infiltrated in the ovarian cancer microenvironment, J. Transl. Med, vol.17, 2019.

J. Kitayama, Y. Atomi, H. Nagawa, A. Kuroda, T. Mutoh et al., Functional analysis of TCR ??+T cells in tumour-infiltrating lymphocytes (TIL) of human pancreatic cancer, Clin. Exp. Immunol, vol.93, pp.442-447, 1993.

J. Lü, R. Aggarwal, S. Kanji, M. Das, M. Joseph et al., Human Ovarian Tumor Cells Escape ?? T Cell Recognition Partly by Down Regulating Surface Expression of MICA and Limiting Cell Cycle Related Molecules, PLoS ONE, vol.6, 2011.

M. Rei, N. G. Sousa, T. Lança, R. G. Thompson, S. Mensurado et al., V?6(+) ?? T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages, Proc. Natl. Acad. Sci, vol.111, pp.3562-3570, 2014.

S. B. Coffelt, K. Kersten, C. W. Doornebal, J. Weiden, K. Vrijland et al., IL-17-producing ?? T cells and neutrophils conspire to promote breast cancer metastasis, Nature, vol.522, pp.345-348, 2015.

S. Ma, Q. Cheng, Y. Cai, H. Gong, Y. Wu et al., IL-17A Produced by T Cells Promotes Tumor Growth in Hepatocellular Carcinoma, Cancer Res, vol.74, 1969.

P. Wu, D. Wu, C. Ni, J. Ye, W. Chen et al., ??T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer, vol.40, pp.785-800, 2014.

Y. Ma, L. Aymeric, C. Locher, S. Mattarollo, N. F. Delahaye et al., Contribution of IL-17-producing ?? T cells to the efficacy of anticancer chemotherapy, J. Exp. Med, vol.208, pp.491-503, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00576679

G. Peng, H. Y. Wang, W. Peng, Y. Kiniwa, K. H. Seo et al., Tumor-Infiltrating ?? T Cells Suppress T and Dendritic Cell Function via Mechanisms Controlled by a Unique Toll-like Receptor Signaling Pathway, Immunity, vol.27, pp.334-348, 2007.

D. Daley, C. P. Zambirinis, L. Seifert, N. Akkad, N. Mohan et al., ?? T Cells Support Pancreatic Oncogenesis by Restraining ?? T Cell Activation, vol.166, pp.1485-1499, 2016.

C. Barjon, H. Michaud, A. Fages, C. Dejou, A. Zampieri et al.,

, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2020 by the authors. Licensee MDPI